Can I Take Creatine with Tirosint (Levothyroxine Liquid/Gel Cap)?

What Tirosint Is and Why the Formulation Comes Up

Tirosint is a liquid-filled gelatin capsule form of levothyroxine sodium. It contains levothyroxine, glycerin, gelatin, and water, without the fillers, dyes, and acacia found in many standard tablets. Some patients with malabsorption issues (celiac disease, gastric bypass, lactose intolerance) are switched to it because those excipients can interfere with tablet absorption in that setting. That background matters for a supplement-interaction question because it explains why levothyroxine formulations are sensitive to co-administered substances that bind the drug or change gastric pH, even when the substance itself, like creatine, is not the source of an interaction here.

What the FDA Label Actually Says About Interacting Substances

The Tirosint prescribing information filed with the FDA addresses drug and food interactions and identifies agents such as calcium supplements, iron supplements, and antacids as requiring separated dosing because they bind levothyroxine or alter its absorption. Creatine is not addressed in the label. That absence is not proof of safety by itself, but it is consistent with creatine's lack of a known binding or pH-altering mechanism, and an editor should confirm the exact wording against the current label before quoting it directly.

Does Creatine Interact with Tirosint Pharmacokinetically?

No pharmacokinetic interaction between creatine and levothyroxine appears in the literature reviewed for this page. The two compounds do not share known metabolic enzymes, plasma protein-binding competition, or intestinal transport mechanisms.

How Creatine Is Handled by the Body

Dietary and supplemental creatine is absorbed in the small intestine, largely via the SLC6A8 transporter, and stored mainly in skeletal muscle. It is not a substrate for hepatic cytochrome P450 metabolism. The International Society of Sports Nutrition's 2017 position stand on creatine describes creatine monohydrate as having a strong overall safety record at typical doses and does not identify clinically significant interactions with common medications, though it is a general position statement rather than a study specifically testing levothyroxine.

How Levothyroxine Is Handled by the Body

Levothyroxine is converted peripherally to active triiodothyronine (T3), mainly by deiodinase enzymes in the liver, kidney, and skeletal muscle. Its absorption depends on gastric acid and intestinal transporters. Creatine has no established effect on these enzymes or transporters, so there is no clear mechanism by which it would change thyroid hormone bioavailability.

A Pharmacodynamic Overlap Worth Naming, Not Overstating

Thyroid hormone and creatine both touch skeletal muscle energy metabolism, but through parallel rather than competing mechanisms: thyroid hormone supports mitochondrial oxidative metabolism, while creatine supports short-burst ATP regeneration via phosphocreatine. Older animal-model work in Endocrinology reported that hypothyroidism reduces skeletal muscle creatine kinase activity and that thyroid hormone replacement partially restores it, which is consistent with a role for thyroid status in muscle creatine-related enzyme activity. This is animal data, not a clinical trial of creatine supplementation in hypothyroid patients, and should be presented that way.

The Creatinine Problem: Why the Lab Panel Gets Confusing

This is the clinically relevant issue with this combination. Creatine is converted non-enzymatically to creatinine in muscle, and supplementing creatine increases the substrate available for that conversion.

Creatine Raises Serum Creatinine Without Necessarily Changing True Kidney Function

Small trials on creatine supplementation have found that several grams per day for a few weeks raises serum creatinine, [with small trials reportedly showing an effect in roughly the 10 to 20 percent range without a corresponding change in cystatin C or measured glomerular filtration rate, reversible after stopping. The exact study design, sample size, and point estimate behind this specific figure should be re-verified against the source before publication, since the citation trail for this claim needs a direct check rather than being taken on faith.

Why This Matters More for a Thyroid Patient

Hypothyroidism is understood to reduce renal blood flow and glomerular filtration rate through several physiological mechanisms, an established point in endocrine and nephrology teaching. A precise epidemiological figure for how much thyroid status shifts population-level GFR was in the original draft of this page but is being removed here because the citation attached to it does not clearly support that specific number; if a quantified association is wanted for the page, it needs a source that actually reports GFR or eGFR data in a thyroid population, not a cardiovascular-outcomes citation. The safe general statement is that thyroid status and kidney function are physiologically linked, so a creatinine change in a hypothyroid patient on creatine has two plausible contributors, not one.

Cystatin C as the Practical Workaround

When a Tirosint patient starts creatine, checking cystatin C alongside standard creatinine is a reasonable way to separate a supplement-driven creatinine rise from a true change in kidney function, since cystatin C is not affected by muscle mass or creatine intake. General nephrology guidance supports using cystatin C-based eGFR when creatinine-based estimates are likely to be unreliable for non-GFR reasons, which is the situation here. An editor should confirm the specific KDIGO recommendation language and year cited against the current guideline text.

Who Faces the Most Practical Risk from the Lab Confusion

Patients with pre-existing chronic kidney disease, those on nephrotoxic medications (NSAIDs, iodinated contrast), and people with poorly controlled diabetes are the group where a creatine-driven creatinine bump is most likely to be misread, either triggering an unnecessary workup or, in the opposite direction, being wrongly dismissed when it is not actually supplement-related.

Does Hypothyroidism Change How Creatine Behaves in Muscle?

Undertreated hypothyroidism is a recognized cause of elevated creatine kinase (CK), sometimes reaching many multiples of the upper limit of normal, because thyroid hormone deficiency impairs muscle enzyme clearance and turnover. This is well established as a general clinical phenomenon. A specific case-series figure for peak CK values was in the original draft of this page attached to a citation that, on inspection, is a general review of causes of rhabdomyolysis rather than a hypothyroidism-specific case series; that exact figure needs a source that actually reports it before it goes back into a published version.

The practical implication does not depend on the exact number: starting creatine while a patient is meaningfully undertreated could add another variable to an already elevated CK, making it harder to distinguish hypothyroid myopathy from a supplement effect or true rhabdomyolysis. Confirming euthyroid status before starting creatine, and rechecking CK a few weeks later if muscle symptoms exist, is the reasonable approach regardless of the precise numbers.

Timing: Does It Matter When Creatine Is Taken Relative to Tirosint?

Because no pharmacokinetic interaction has been identified, strict separation is not required for creatine the way it is for calcium or iron. The standard Tirosint instructions cover this adequately.

The Standard Tirosint Protocol

Take Tirosint on an empty stomach, 30 to 60 minutes before food, coffee, or other supplements. The American Thyroid Association's 2014 guidelines on hypothyroidism management support taking levothyroxine consistently, separated from potentially interfering substances, as a general principle of stable dosing; an editor should confirm this page paraphrases rather than misquotes the guideline text.

Where Creatine Fits

Creatine taken with breakfast, post-workout, or at any point after the Tirosint absorption window has passed is reasonable. There is no evidence reviewed here that creatine taken later in the day affects levothyroxine that has already been absorbed.

Evidence-Status Assessment: Creatine and Tirosint

This assessment separates what is documented, what is biologically plausible but unstudied, what is not established, and what still needs direct source verification before this page is finalized. It was built for this page from the sources listed above and is not a reproduction of any single published protocol.

Before a clinician or pharmacist should sign off on this page: re-verify every PubMed citation against its actual title and abstract, confirm the FDA label and ATA guideline paraphrases against current source text rather than treating the quotations in the original draft as verbatim, and either source or remove the specific numeric claims flagged above (the GFR percentage, the CK case-series figure, and the tablet-versus-Tirosint Cmax comparison).

What This Means in Practice

For most adults who are euthyroid on a stable Tirosint dose and have normal kidney function, the available evidence does not point to a reason to avoid combining creatine with Tirosint. The main action item is disclosure and monitoring, not avoidance: tell the prescribing clinician about creatine use so a creatinine rise on a future panel is interpreted correctly, and get a baseline creatinine (with cystatin C if there is any pre-existing kidney concern) before starting.

Patients with significant chronic kidney disease, uncontrolled hypothyroidism, or a recent Tirosint dose change are the groups where waiting for stability, or getting individualized clearance, makes more sense than starting creatine immediately.

Timing is straightforward: take Tirosint first, on an empty stomach, wait 30 to 60 minutes, then take creatine with food, a shake, or around a workout at any later point in the day.